Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Sonawalla, S. B. Articles by Fava, M. Search for Related Content PubMed Citation Articles by Sonawalla, S. B. Articles by Fava, M. Neurophysiology Depression Antidepressants

Compounds Containing Cytosolic Choline in the Basal Ganglia: A Potential Biological Marker of True Drug Response to Fluoxetine

OBJECTIVE: Studies have identified two types of antidepressant response: true drug response and placebo pattern response. This study examined the relationship between true drug response and choline-creatine ratios in the basal ganglia of depressed patients treated with fluoxetine. METHOD: The authors evaluated drug-free outpatients with major depression before (N=41) and after (N=15) 8 weeks of fluoxetine treatment, 20 mg/day, by using proton magnetic resonance spectroscopy. RESULTS: There was a significant difference in the degree of change from baseline to week 8 in choline-creatine ratios between the true drug response group (N=8) and the placebo pattern response/nonresponse group (N=7); the true drug response patients had a 20% increase in choline-creatine ratios, and the placebo pattern response/nonresponse patients had a 12% decrease in choline-creatine ratios. CONCLUSIONS: These data suggest that true drug response to fluoxetine treatment in depression may be associated with an increase in choline-creatine ratios in the basal ganglia.

This article has been cited by other articles:

				V. Gabbay, D. A. Hess, S. Liu, J. S. Babb, R. G. Klein, and O. Gonen Lateralized Caudate Metabolic Abnormalities in Adolescent Major Depressive Disorder: A Proton MR Spectroscopy Study Am J Psychiatry, December 1, 2007; 164(12): 1881 - 1889. [Abstract] [Full Text] [PDF]

				R. B. Sassi, J. A. Stanley, D. Axelson, P. Brambilla, M. A. Nicoletti, M. S. Keshavan, R. T. Ramos, N. Ryan, B. Birmaher, and J. C. Soares Reduced NAA Levels in the Dorsolateral Prefrontal Cortex of Young Bipolar Patients Am J Psychiatry, November 1, 2005; 162(11): 2109 - 2115. [Abstract] [Full Text] [PDF]

				S. R. Dager, S. D. Friedman, A. Parow, C. Demopulos, A. L. Stoll, I. K. Lyoo, D. L. Dunner, and P. F. Renshaw Brain Metabolic Alterations in Medication-Free Patients With Bipolar Disorder Arch Gen Psychiatry, May 1, 2004; 61(5): 450 - 458. [Abstract] [Full Text] [PDF]

				A. F. Leuchter, I. A. Cook, E. A. Witte, M. Morgan, and M. Abrams Changes in Brain Function of Depressed Subjects During Treatment With Placebo Am J Psychiatry, January 1, 2002; 159(1): 122 - 129. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us